DANA DAVENPORT: Open Payments
NPI 1710347844 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 50 payments from 16 companies in 2025. Trend: 2023 $662 · 2024 $1,588 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $171 |
| Novo Nordisk Inc | 10 | $146 |
| AstraZeneca Pharmaceuticals LP | 6 | $113 |
| Eisai Inc. | 4 | $77 |
| Lilly USA, LLC | 3 | $56 |
| ABBVIE INC. | 2 | $53 |
| Amneal Pharmaceuticals LLC | 1 | $35 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Lundbeck LLC | 1 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: NURTEC ODT, Leqembi, AIRSUPRA, Ozempic, Wegovy, JARDIANCE, FARXIGA, CREXONT.
Industry payments across TX — which companies pay providers there.
